报价延迟最少15分钟:2026/05/27 22:31 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.56 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.83/--
|
|
企业价值
34.27M
|
| 资产负债 |
|
每股账面净值
0.77
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
124.16K
|
|
每股收益
0.02
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format. |
